Management of AML Beyond “3 + 7” in 2019
The therapeutic paradigm for treatment of acute myeloid leukemia (AML) is rapidly changing with the advent of a new generation of drugs targeting diverse aspects of leukemogenesis. Whereas standard treatment for AML until recently consisted of a classic chemotherapy backbone, the incorporation of no...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAABRON PRESS
2019-03-01
|
| Series: | Clinical Hematology International |
| Subjects: | |
| Online Access: | https://www.atlantis-press.com/article/125905873/view |